Investing in research and development is part of a larger strategy to strengthen Canada's economy amid growing global ...

The government launched a two-year pilot of a genomic testing programme, allowing samples to be analysed locally. Health ...

Living with a rare disease often means years of uncertainty, misdiagnosis, and limited treatment options. But advances in ...

Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, and ...

Helio Genomics, an AI-powered TechBio company focused on early cancer detection, today announced an agreement with Quest ...

The Atlas will expand known evolutionary genetic diversity by 100x, collecting novel genomic data from over 100 million new ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...

Cooper Medical School of Rowan University (CMSRU) has launched the PhD in Cancer Cell Biology & Genomics (CCBG), a new ...

Neogen Corp. in Lansing, a leader in food safety solutions, has entered into a definitive agreement to sell its global ...

Facing the loss of his beloved rescue dog, a tech entrepreneur enlisted AI and ChatGPT to co-develop an experimental cancer ...

Learn more about whether Revvity, Inc. or 10x Genomics, Inc. is a better investment based on AAII's A+ Investor grades, which ...

A novel approach has identified drugs in current use that could be repurposed for treating alcohol use disorder (AUD). In 2023, 28 million US adults had experienced AUD in the past year. But only ...